Nuveen’s Diebold Nixdorf DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.1M Sell
224,256
-30,038
-12% -$2.42M ﹤0.01% 1293
2026
Q1
$19.2M Buy
254,294
+13,292
+6% +$978K 0.01% 1161
2025
Q4
$16.4M Sell
241,002
-59,532
-20% -$3.72M ﹤0.01% 1264
2025
Q3
$17.1M Buy
300,534
+50,322
+20% +$2.98M ﹤0.01% 1241
2025
Q2
$13.9M Buy
250,212
+3,282
+1% +$154K ﹤0.01% 1308
2025
Q1
$10.8M Sell
246,930
-1,415
-0.6% -$61.7K ﹤0.01% 1510
2024
Q4
$10.7M Buy
248,345
+107
+0% +$4.82K ﹤0.01% 1565
2024
Q3
$11.1M Buy
248,238
+78,137
+46% +$3.23M ﹤0.01% 1538
2024
Q2
$6.55M Buy
+170,101
New +$6.48M ﹤0.01% 1813

Other funds holding DBD

Nuveen's DBD Position: Q2 2026 in Review

Nuveen reduced its Diebold Nixdorf (DBD) stake by 12% in Q2 2026, selling an estimated $2.42M and leaving 224,256 shares worth $19.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1293.

Nuveen first reported a position in DBD in Q2 2024 and has held it in 9 quarters since. The position peaked at $19.2M in Q1 2026. 216 funds tracked by Wall St. Rank hold DBD as of Q2 2026.

  • Nuveen held 224,256 shares of Diebold Nixdorf worth $19.1M as of Q2 2026.
  • Nuveen sold 30,038 Diebold Nixdorf shares in Q2 2026, an estimated $2.42M.
  • Diebold Nixdorf made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #1293 holding.
  • Nuveen first reported a position in Diebold Nixdorf in Q2 2024 and has held it in 9 quarters since.
  • Nuveen's Diebold Nixdorf position peaked at $19.2M in Q1 2026.
  • 216 funds tracked by Wall St. Rank held Diebold Nixdorf as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.